Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Amend Cannabis has shown a dynamic performance across its product categories, particularly in the Topical category within Missouri. Notably, the brand ranked 6th in January 2025, indicating a strong presence in the market. However, the absence of a ranking in February 2025 suggests that Amend Cannabis did not maintain its position within the top 30 brands during that month. This could be seen as a setback, but the brand managed to recover slightly by March 2025, securing the 7th position. This fluctuation highlights the competitive nature of the cannabis market in Missouri and suggests that Amend Cannabis is actively working to regain and stabilize its market share.
Despite the challenges in maintaining a consistent top-tier ranking, Amend Cannabis's sales figures reflect a resilient brand. For instance, the sales in January 2025 were $10,220, which slightly decreased in March to $10,028. This modest decline in sales, coupled with the fluctuating rankings, underscores the importance of strategic positioning and adaptability in the cannabis industry. The absence of a ranking in April 2025 further emphasizes the volatility and competitive pressures within the market. Observing these trends offers valuable insights into the brand's performance and potential areas for improvement, especially in maintaining a stable presence in the top rankings.
Competitive Landscape
In the Missouri topical cannabis market, Amend Cannabis has faced fluctuating rankings and sales, indicating a competitive landscape that demands strategic adjustments. In January 2025, Amend Cannabis held the 6th position, but by March, they slipped to 7th, with no ranking in February and April, suggesting they fell out of the top 20 during those months. This inconsistency contrasts with competitors like Vlasic Labs, which improved from 5th to 4th place by March and maintained that rank in April, and Heartland Holistics, which consistently stayed in the top 5. The sales trajectory of Vlasic Labs shows a steady increase, while Heartland Holistics experienced slight fluctuations but remained robust. Drool, another competitor, showed improvement from 7th to 6th in March, further intensifying the competition. These dynamics highlight the need for Amend Cannabis to innovate and enhance its market strategies to regain and stabilize its position in the Missouri topical category.
Notable Products
In April 2025, the top-performing product from Amend Cannabis was the CBD/THC/CBC 1:1:1 Transdermal Lotion (100mg CBD, 100mg THC, 100mg CBC) in the Topical category, maintaining its number 1 rank from March despite a drop in sales to 191 units. The CBD/THC 1:1 Amend Tincture, a Tincture & Sublingual product, held steady at rank 2, showing consistent performance over the months. The CBD/THC 1:1 Amend Infused Balm, another Topical product, ranked 3rd, slipping from its number 1 position in February. The CBD/THC/CBC 1:1:1 Transdermal Lotion (50mg CBD, 50mg THC, 50mg CBC) re-entered the rankings at position 4, after not being ranked in February and March. Lastly, the CBD/THC/CBC 1:1:1 Transdermal Lotion (500mg CBD, 500mg THC, 500mg CBC) maintained its 5th place ranking from March, despite a continued decrease in sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.